Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Bader

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Tree Physiology|February 11, 2009
Water relations and photosynthetic performance in Larix sibirica growing in the forest-steppe ecotone of northern MongoliaChoimaa Dulamsuren, Markus Hauck, Martin Bader, et al.
International Journal of Pharmaceutics: X|January 23, 2023
End-to-end approach for the characterization and control of product-related impurities in T cell bispecific antibody preparationsLaurent Larivière, Julia Eva Krüger, Thomas von Hirschheydt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibodyJens A A Fischer, Axel J Hueber, Stacy Wilson, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Tree Physiology|February 11, 2009
Water relations and photosynthetic performance in Larix sibirica growing in the forest-steppe ecotone of northern MongoliaChoimaa Dulamsuren, Markus Hauck, Martin Bader, et al.
International Journal of Pharmaceutics: X|January 23, 2023
End-to-end approach for the characterization and control of product-related impurities in T cell bispecific antibody preparationsLaurent Larivière, Julia Eva Krüger, Thomas von Hirschheydt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibodyJens A A Fischer, Axel J Hueber, Stacy Wilson, et al.
Pageof 2